interactions: BB, CYP2C9 inducers, CYP2C9 inhibitors, FQs/NSAIDs/fenofibrate/SSRIs/somatostatin analogues (altered glucose metabolism and increased risk of hypoglycemia and hyperglycemia), MAOIs (stimulation of insulin secretion, hypoglycemic effects), psyllium (may delay absorption of glucose from meals, hypoglycemic effects), sulfonamides (increased risk of hypoglycemia)